Abstract:Background Allergic asthma is a chronic airway inflammatory disease with a number of cytokines participating in its pathogenesis and progress. Interleukin (IL)-22, which is derived from lymphocytes, acts on epithelial cells and play a role in the chronic airway inflammation. However, the actual role of IL-22 in allergic asthma is still unclear. Therefore, we explored the effect of IL-22 on allergic airway inflammation and airway hyperresponsiveness (AHR) in an ovalbumin (OVA)-induced asthma mouse model. Methods To evaluate the effect of IL-22 in an allergic asthma model, BALB/c mice were sensitized and challenged with OVA; then the recombinant mouse IL-22 was administered intranasally 24 h prior to each challenge. The IL-22 levels in lung homogenates and bronchoalveolar lavage fluid (BALF) were measured by enzyme linked immunosorbent assay, respectively. AHR was evaluated through indicators including airways resistance (Rrs), elastance (Ers) and compliance (Crs); the inflammatory cell infiltration was assessed by quantification of differential cells counts in BALF and lung tissues stained by hematoxylin and eosin (H&E); IL-22 specific receptors were determined by immunohistochemistry staining. Results The concentration of IL-22 was significantly elevated in the OVA-induced mice compared with the control mice in lung homogenates and BALF. In the OVA-induced mouse model, IL-22 administration could significantly attenuate AHR, including Rrs, Ers and Crs, decrease the proportion of eosinophils in BALF and reduce inflammatory cell infiltration around bronchi and their concomitant vessels, compared with the OVA-induced group. In addition, the expression of IL-22RA1 and IL-10RB in the lung tissues of OVA-induced mice was significantly increased compared with the control mice, while it was dramatically decreased after the treatment with IL-22, but not completely attenuated in the IL-22-treated mice when compared with the control mice. Conclusion Interleukin-22 could play a protective role in an OVA-induced asthma model, by suppressing the inflammatory cell infiltration around bronchi and their concomitant vessels and airway hyperresponsiveness, which might associate with the expression of its heterodimer receptors. Thus, IL-22 administration might be an effective strategy to attenuate allergic airway inflammation.

Cytokine antibody array-based analysis of IL-37 treatment effects in asthma

IL‐37 Inhibits IL‐4/IL‐13‐induced CCL11 Production and Lung Eosinophilia in Murine Allergic Asthma

Attenuated airways inflammation and remodeling in IL-37a and IL-37b transgenic mice with an ovalbumin-induced chronic asthma

Assessment of Tumor Growth Factor-Β1 Neutralizing Antibody in the Treatment of Allergic Rhinitis and Asthma.

Insight into Interleukin-37: the Potential Therapeutic Target in Allergic Diseases

IL-37 Protects Against House Dust Mite-Induced Airway Inflammation and Airway Epithelial Barrier Dysfunction Via Inhibiting Store-Operated Calcium Entry

Anti-Inflammatory Effect of IL-37b in Children with Allergic Rhinitis

Decreased Circulating Interleukin-35 Levels Are Related to Interleukin-4-Producing CD8+ T Cells in Patients with Allergic Asthma.

Interleukin-31 Expression and Relation to Disease Severity in Human Asthma.

Selective production of IL-33-neutralizing autoantibody ameliorates asthma responses and severity

A potential immunopathogenic role for reduced IL-35 expression in allergic asthma

Anti-inflammatory mechanisms of the novel cytokine interleukin-38 in allergic asthma

Effect of Interleukin-33 on Th1/Th2 Cytokine Ratio in Peripheral Lymphocytes in Asthmatic Mice.

Interleukin-36 Receptor Antagonist Alleviates Airway Inflammation in Asthma Via Inhibiting the Activation of Interleukin-36 Pathway.

The Expression of A Novel Anti-Inflammatory Cytokine Il-35 and Its Possible Significance in Childhood Asthma

IL-37 Ameliorating Allergic Inflammation in Atopic Dermatitis Through Regulating Microbiota and AMPK-mTOR Signaling Pathway-Modulated Autophagy Mechanism

IL-38 alleviates airway remodeling in chronic asthma via blocking the profibrotic effect of IL-36γ

Interleukin-22 attenuates allergic airway inflammation in ovalbumin-induced asthma mouse model

IL-36 Cytokines: Their Roles in Asthma and Potential as a Therapeutic

Decreased concentration of IL-35 in plasma of patients with asthma and COPD.

Human host defence peptide LL-37 suppresses TNFα-mediated matrix metalloproteinases MMP9 and MMP13, in human bronchial epithelial cells